Matches in Nanopublications for { ?s ?p "[NOTCH1 pathway activation represents a common feature of T-ALL when compared to acute myelogenous leukemia (AML) and B-cell precursor acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP326419.RATx-SOGbkw7BpA7hbCbAQ35NY71NhViLlJ_gGzQD4dCw130_assertion description "[NOTCH1 pathway activation represents a common feature of T-ALL when compared to acute myelogenous leukemia (AML) and B-cell precursor acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326419.RATx-SOGbkw7BpA7hbCbAQ35NY71NhViLlJ_gGzQD4dCw130_provenance.
- NP288313.RAg0b3HXAGUzEq6KZbN9XPDDTJjdjz8CVcdzM0lRkfSgc130_assertion description "[NOTCH1 pathway activation represents a common feature of T-ALL when compared to acute myelogenous leukemia (AML) and B-cell precursor acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP288313.RAg0b3HXAGUzEq6KZbN9XPDDTJjdjz8CVcdzM0lRkfSgc130_provenance.
- NP346214.RAaTICsM2t7t9G4wxp-EpWrOFoG25RPdJYkztaXrJ-Rz4130_assertion description "[NOTCH1 pathway activation represents a common feature of T-ALL when compared to acute myelogenous leukemia (AML) and B-cell precursor acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP346214.RAaTICsM2t7t9G4wxp-EpWrOFoG25RPdJYkztaXrJ-Rz4130_provenance.
- assertion description "[NOTCH1 pathway activation represents a common feature of T-ALL when compared to acute myelogenous leukemia (AML) and B-cell precursor acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[NOTCH1 pathway activation represents a common feature of T-ALL when compared to acute myelogenous leukemia (AML) and B-cell precursor acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[NOTCH1 pathway activation represents a common feature of T-ALL when compared to acute myelogenous leukemia (AML) and B-cell precursor acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP479526.RAQ9N9JWuxl7wNCuG_rEpyBRE3FkSug_R6EZ4ej42r_tI130_assertion description "[NOTCH1 pathway activation represents a common feature of T-ALL when compared to acute myelogenous leukemia (AML) and B-cell precursor acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP479526.RAQ9N9JWuxl7wNCuG_rEpyBRE3FkSug_R6EZ4ej42r_tI130_provenance.
- NP479530.RAWikerSw-Qbgx0LVlrBxqeLWy8TVynea1eij0XI9X-fo130_assertion description "[NOTCH1 pathway activation represents a common feature of T-ALL when compared to acute myelogenous leukemia (AML) and B-cell precursor acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP479530.RAWikerSw-Qbgx0LVlrBxqeLWy8TVynea1eij0XI9X-fo130_provenance.
- NP479527.RAz08AMbLkmJ6GUewqPBsGpRmNPxJoHktiCN5aRcbwsPw130_assertion description "[NOTCH1 pathway activation represents a common feature of T-ALL when compared to acute myelogenous leukemia (AML) and B-cell precursor acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP479527.RAz08AMbLkmJ6GUewqPBsGpRmNPxJoHktiCN5aRcbwsPw130_provenance.